Pharmaceutics International, Inc.
Pharmaceutics International, Inc. (PII), headquartered in the United States, is a leading player in the pharmaceutical contract development and manufacturing industry. Founded in 1997, the company has established a strong presence in key operational regions, including North America and Europe. PII specialises in the formulation and production of complex drug products, particularly in the areas of injectable and oral dosage forms. With a commitment to innovation, Pharmaceutics International offers unique services such as customised formulation development and comprehensive analytical testing. The company has achieved notable milestones, including successful partnerships with major pharmaceutical firms, which solidify its market position as a trusted provider in the industry. PII's dedication to quality and regulatory compliance sets it apart, making it a preferred choice for clients seeking reliable pharmaceutical solutions.
DitchCarbon Score
How does Pharmaceutics International, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaceutics International, Inc.'s score of 37 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmaceutics International, Inc.'s reported carbon emissions
Pharmaceutics International, Inc., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many organisations in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprints across various scopes of emissions. However, without specific information from Pharmaceutics International, Inc., it is not possible to detail their individual commitments or achievements in this area.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaceutics International, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
